ARCHIVES

Nurse Oncology Society Growing, developing Care Guidelines

This article is from The Cancer Letter archive.

Vol. 03 No. 33 | August 19, 1977

Download PDF Visit The Full Archive

Related Articles

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

NCI Advisory Group, Other Cancer Meetings

May 29, 1987

NCI Bypass Budget For FY 1992 Requests $2.6 Billion Support grows In Congress

May 18, 1990

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

August 29, 2014

ASCO: NCI Director Should Be A Clinician; NBCC Endorses Mary-Claire King

March 10, 1995